5-Chloro-3-(2-methylimidazol-1-ylmethyl)-pyridazine → HCID 22240276, compound

HRID 891917Notes

Reaction equation

HRID 891917 reaction equation
[CH3:1][O:2][C:3]1[CH:12]=[CH:11][C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[C:4]=1B1OC(C)(C)C(C)(C)O1.[Cl:22][C:23]1[CH:24]=[C:25]([CH2:29][N:30]2[CH:34]=[CH:33][N:32]=[C:31]2[CH3:35])[N:26]=[N:27][CH:28]=1>>[ClH:22].[CH3:1][O:2][C:3]1[CH:12]=[CH:11][C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[C:4]=1[C:23]1[CH:24]=[C:25]([CH2:29][N:30]2[CH:34]=[CH:33][N:32]=[C:31]2[CH3:35])[N:26]=[N:27][CH:28]=1

Participants

3

Procedure

The title compound, MS: m/e=331.3 (M+H+), was prepared from 2-(2-methoxy-naphthalen-1-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane and 5-chloro-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine.

Sources & evidence

ORD record
ord-2c12813629aa49fa9086e12a40dc81f3
Source dataset
uspto-grants-2006_02
Patent number
US07005432B2

Reaction notes

Loading…